← All investors

Family Office

SK Capital Partners

Parramatta, NSW, Australia

Type

Family Office

Check size

n/a

Verticals

specialty materials, ingredients, life sciences

Investment thesis

SK Capital Partners is a private investment firm founded in 2007, specializing in the chemicals, materials, and pharmaceuticals sectors. Headquartered in New York City, the firm manages more than $7 billion in assets and focuses on acquiring and building businesses with strong growth potential. SK Capital Partners is known for its operational expertise and has a portfolio that includes several prominent companies in specialty chemicals and pharmaceuticals. The firm has a track record of driving transformation and value creation in its investments, with recent activity including strategic acquisitions and divestitures in its core industries.

Recent investments

  • Apotex
  • Spectrum Vascular
  • Axillon Aerospace

+ 3 more deals. Score your deck to see the full investment history.

Partners

5 partners on file at this firm, with the firm's email pattern for cold outreach.

Partner names + email patterns are part of the deck-upload bundle. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 8,600+ others.

Score my deck → unlock contacts

Investment focus

Business models

services, biotech_therapeutics

Customer segments

Enterprise, Mid-market

Geography

US, Europe, APAC, LATAM

Links

Want to know if SK Capital Partners is the right fit for your deck?

Drop your pitch deck. Claude scores it on the 8 dimensions VCs evaluate and tells you which of the 8,665 firms in our database are the best matches.

Score your deck (free, 30 seconds) →

Similar investors